Click for best price
Atypical Antipsychotic Drugs Market Size, Share 2022
Atypical antipsychotic drugs are a type of antipsychotic drugs used in treatment of psychosis. They do not cure psychosis but help in controlling symptoms such as hallucinations, and delusions, among others.
This report contains market size and forecasts of Atypical Antipsychotic Drugs in global, including the following market information:
Global Atypical Antipsychotic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Atypical Antipsychotic Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Atypical Antipsychotic Drugs companies in 2021 (%)
The global Atypical Antipsychotic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Risperidone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Atypical Antipsychotic Drugs include Novartis AG, Cardinal Health, Johnson and Johnson, Allergan, Sanis Health, Pfizer, GlaxoSmithKline, Bristol-Myers Squibb Company and Sun Pharmaceutical Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Atypical Antipsychotic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atypical Antipsychotic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Atypical Antipsychotic Drugs Market Segment Percentages, by Type, 2021 (%)
Risperidone
Olanzapine
Quetiapine
Ziprasidone
Others
Global Atypical Antipsychotic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Atypical Antipsychotic Drugs Market Segment Percentages, by Application, 2021 (%)
Bipolar I Disorder
Schizophrenia
Schizoaffective Disorder
Major Depressive Disorder (MDD)
Global Atypical Antipsychotic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Atypical Antipsychotic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atypical Antipsychotic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Atypical Antipsychotic Drugs revenues share in global market, 2021 (%)
Key companies Atypical Antipsychotic Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Atypical Antipsychotic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Cardinal Health
Johnson and Johnson
Allergan
Sanis Health
Pfizer
GlaxoSmithKline
Bristol-Myers Squibb Company
Sun Pharmaceutical Industries
Eil Lilly and Company
AstraZeneca
Sumitomo Dainippon Pharma
Qilu Pharmaceutical
| Report Attributes |
Report Details |
| Report Title |
Atypical Antipsychotic Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
70 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Atypical Antipsychotic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Atypical Antipsychotic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Atypical Antipsychotic Drugs Overall Market Size
2.1 Global Atypical Antipsychotic Drugs Market Size: 2021 VS 2028
2.2 Global Atypical Antipsychotic Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Atypical Antipsychotic Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Atypical Antipsychotic Drugs Players in Global Market
3.2 Top Global Atypical Antipsychotic Drugs Companies Ranked by Revenue
3.3 Global Atypical Antipsychotic Drugs Revenue by Companies
3.4 Global Atypical Antipsychotic Drugs Sales by Companies
3.5 Global Atypical Antipsychotic Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Atypical Antipsychotic Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Atypical Antipsychotic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Atypical Antipsychotic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Atypical Antipsychotic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Atypical Antipsychotic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Atypical Antipsychotic Drugs Market Size Markets, 2021 & 2028
4.1.2 Risperidone
4.1.3 Olanzapine
4.1.4 Quetiapine
4.1.5 Ziprasidone
4.1.6 Others
4.2 By Type - Global Atypical Antipsychotic Drugs Revenue & Forecasts
4.2.1 By Type - Global Atypical Antipsychotic Drugs Revenue, 2017-2022
4.2.2 By Type - Global Atypical Antipsychotic Drugs Revenue, 2023-2028
4.2.3 By Type - Global Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Atypical Antipsychotic Drugs Sales & Forecasts
4.3.1 By Type - Global Atypical Antipsychotic Drugs Sales, 2017-2022
4.3.2 By Type - Global Atypical Antipsychotic Drugs Sales, 2023-2028
4.3.3 By Type - Global Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Atypical Antipsychotic Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Atypical Antipsychotic Drugs Market Size, 2021 & 2028
5.1.2 Bipolar I Disorder
5.1.3 Schizophrenia
5.1.4 Schizoaffective Disorder
5.1.5 Major Depressive Disorder (MDD)
5.2 By Application - Global Atypical Antipsychotic Drugs Revenue & Forecasts
5.2.1 By Application - Global Atypical Antipsychotic Drugs Revenue, 2017-2022
5.2.2 By Application - Global Atypical Antipsychotic Drugs Revenue, 2023-2028
5.2.3 By Application - Global Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Atypical Antipsychotic Drugs Sales & Forecasts
5.3.1 By Application - Global Atypical Antipsychotic Drugs Sales, 2017-2022
5.3.2 By Application - Global Atypical Antipsychotic Drugs Sales, 2023-2028
5.3.3 By Application - Global Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Atypical Antipsychotic Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Atypical Antipsychotic Drugs Market Size, 2021 & 2028
6.2 By Region - Global Atypical Antipsychotic Drugs Revenue & Forecasts
6.2.1 By Region - Global Atypical Antipsychotic Drugs Revenue, 2017-2022
6.2.2 By Region - Global Atypical Antipsychotic Drugs Revenue, 2023-2028
6.2.3 By Region - Global Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Atypical Antipsychotic Drugs Sales & Forecasts
6.3.1 By Region - Global Atypical Antipsychotic Drugs Sales, 2017-2022
6.3.2 By Region - Global Atypical Antipsychotic Drugs Sales, 2023-2028
6.3.3 By Region - Global Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Atypical Antipsychotic Drugs Revenue, 2017-2028
6.4.2 By Country - North America Atypical Antipsychotic Drugs Sales, 2017-2028
6.4.3 US Atypical Antipsychotic Drugs Market Size, 2017-2028
6.4.4 Canada Atypical Antipsychotic Drugs Market Size, 2017-2028
6.4.5 Mexico Atypical Antipsychotic Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Atypical Antipsychotic Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Atypical Antipsychotic Drugs Sales, 2017-2028
6.5.3 Germany Atypical Antipsychotic Drugs Market Size, 2017-2028
6.5.4 France Atypical Antipsychotic Drugs Market Size, 2017-2028
6.5.5 U.K. Atypical Antipsychotic Drugs Market Size, 2017-2028
6.5.6 Italy Atypical Antipsychotic Drugs Market Size, 2017-2028
6.5.7 Russia Atypical Antipsychotic Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Atypical Antipsychotic Drugs Market Size, 2017-2028
6.5.9 Benelux Atypical Antipsychotic Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Atypical Antipsychotic Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Atypical Antipsychotic Drugs Sales, 2017-2028
6.6.3 China Atypical Antipsychotic Drugs Market Size, 2017-2028
6.6.4 Japan Atypical Antipsychotic Drugs Market Size, 2017-2028
6.6.5 South Korea Atypical Antipsychotic Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Atypical Antipsychotic Drugs Market Size, 2017-2028
6.6.7 India Atypical Antipsychotic Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Atypical Antipsychotic Drugs Revenue, 2017-2028
6.7.2 By Country - South America Atypical Antipsychotic Drugs Sales, 2017-2028
6.7.3 Brazil Atypical Antipsychotic Drugs Market Size, 2017-2028
6.7.4 Argentina Atypical Antipsychotic Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Atypical Antipsychotic Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Atypical Antipsychotic Drugs Sales, 2017-2028
6.8.3 Turkey Atypical Antipsychotic Drugs Market Size, 2017-2028
6.8.4 Israel Atypical Antipsychotic Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Atypical Antipsychotic Drugs Market Size, 2017-2028
6.8.6 UAE Atypical Antipsychotic Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporate Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Atypical Antipsychotic Drugs Major Product Offerings
7.1.4 Novartis AG Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Novartis AG Key News
7.2 Cardinal Health
7.2.1 Cardinal Health Corporate Summary
7.2.2 Cardinal Health Business Overview
7.2.3 Cardinal Health Atypical Antipsychotic Drugs Major Product Offerings
7.2.4 Cardinal Health Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Cardinal Health Key News
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Corporate Summary
7.3.2 Johnson and Johnson Business Overview
7.3.3 Johnson and Johnson Atypical Antipsychotic Drugs Major Product Offerings
7.3.4 Johnson and Johnson Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Johnson and Johnson Key News
7.4 Allergan
7.4.1 Allergan Corporate Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan Atypical Antipsychotic Drugs Major Product Offerings
7.4.4 Allergan Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Allergan Key News
7.5 Sanis Health
7.5.1 Sanis Health Corporate Summary
7.5.2 Sanis Health Business Overview
7.5.3 Sanis Health Atypical Antipsychotic Drugs Major Product Offerings
7.5.4 Sanis Health Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Sanis Health Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Atypical Antipsychotic Drugs Major Product Offerings
7.6.4 Pfizer Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Pfizer Key News
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Corporate Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Atypical Antipsychotic Drugs Major Product Offerings
7.7.4 GlaxoSmithKline Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.7.5 GlaxoSmithKline Key News
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Corporate Summary
7.8.2 Bristol-Myers Squibb Company Business Overview
7.8.3 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Major Product Offerings
7.8.4 Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Bristol-Myers Squibb Company Key News
7.9 Sun Pharmaceutical Industries
7.9.1 Sun Pharmaceutical Industries Corporate Summary
7.9.2 Sun Pharmaceutical Industries Business Overview
7.9.3 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Major Product Offerings
7.9.4 Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Sun Pharmaceutical Industries Key News
7.10 Eil Lilly and Company
7.10.1 Eil Lilly and Company Corporate Summary
7.10.2 Eil Lilly and Company Business Overview
7.10.3 Eil Lilly and Company Atypical Antipsychotic Drugs Major Product Offerings
7.10.4 Eil Lilly and Company Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Eil Lilly and Company Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca Atypical Antipsychotic Drugs Business Overview
7.11.3 AstraZeneca Atypical Antipsychotic Drugs Major Product Offerings
7.11.4 AstraZeneca Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Sumitomo Dainippon Pharma
7.12.1 Sumitomo Dainippon Pharma Corporate Summary
7.12.2 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Business Overview
7.12.3 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Major Product Offerings
7.12.4 Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Sumitomo Dainippon Pharma Key News
7.13 Qilu Pharmaceutical
7.13.1 Qilu Pharmaceutical Corporate Summary
7.13.2 Qilu Pharmaceutical Atypical Antipsychotic Drugs Business Overview
7.13.3 Qilu Pharmaceutical Atypical Antipsychotic Drugs Major Product Offerings
7.13.4 Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Qilu Pharmaceutical Key News
8 Global Atypical Antipsychotic Drugs Production Capacity, Analysis
8.1 Global Atypical Antipsychotic Drugs Production Capacity, 2017-2028
8.2 Atypical Antipsychotic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Atypical Antipsychotic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Atypical Antipsychotic Drugs Supply Chain Analysis
10.1 Atypical Antipsychotic Drugs Industry Value Chain
10.2 Atypical Antipsychotic Drugs Upstream Market
10.3 Atypical Antipsychotic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Atypical Antipsychotic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Atypical Antipsychotic Drugs in Global Market
Table 2. Top Atypical Antipsychotic Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Atypical Antipsychotic Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Atypical Antipsychotic Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Atypical Antipsychotic Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Atypical Antipsychotic Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Atypical Antipsychotic Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Atypical Antipsychotic Drugs Product Type
Table 9. List of Global Tier 1 Atypical Antipsychotic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Atypical Antipsychotic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Atypical Antipsychotic Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Atypical Antipsychotic Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Atypical Antipsychotic Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Atypical Antipsychotic Drugs Sales (K Units), 2023-2028
Table 16. By Application ? Global Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Atypical Antipsychotic Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Atypical Antipsychotic Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Atypical Antipsychotic Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Atypical Antipsychotic Drugs Sales (K Units), 2023-2028
Table 21. By Region ? Global Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Atypical Antipsychotic Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Atypical Antipsychotic Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Atypical Antipsychotic Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Atypical Antipsychotic Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Atypical Antipsychotic Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Atypical Antipsychotic Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Atypical Antipsychotic Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Atypical Antipsychotic Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Atypical Antipsychotic Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Atypical Antipsychotic Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Atypical Antipsychotic Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Atypical Antipsychotic Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Atypical Antipsychotic Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Atypical Antipsychotic Drugs Sales, (K Units), 2023-2028
Table 46. Novartis AG Corporate Summary
Table 47. Novartis AG Atypical Antipsychotic Drugs Product Offerings
Table 48. Novartis AG Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Cardinal Health Corporate Summary
Table 50. Cardinal Health Atypical Antipsychotic Drugs Product Offerings
Table 51. Cardinal Health Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Johnson and Johnson Corporate Summary
Table 53. Johnson and Johnson Atypical Antipsychotic Drugs Product Offerings
Table 54. Johnson and Johnson Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Allergan Corporate Summary
Table 56. Allergan Atypical Antipsychotic Drugs Product Offerings
Table 57. Allergan Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Sanis Health Corporate Summary
Table 59. Sanis Health Atypical Antipsychotic Drugs Product Offerings
Table 60. Sanis Health Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Pfizer Corporate Summary
Table 62. Pfizer Atypical Antipsychotic Drugs Product Offerings
Table 63. Pfizer Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. GlaxoSmithKline Corporate Summary
Table 65. GlaxoSmithKline Atypical Antipsychotic Drugs Product Offerings
Table 66. GlaxoSmithKline Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Bristol-Myers Squibb Company Corporate Summary
Table 68. Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Product Offerings
Table 69. Bristol-Myers Squibb Company Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Sun Pharmaceutical Industries Corporate Summary
Table 71. Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Product Offerings
Table 72. Sun Pharmaceutical Industries Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Eil Lilly and Company Corporate Summary
Table 74. Eil Lilly and Company Atypical Antipsychotic Drugs Product Offerings
Table 75. Eil Lilly and Company Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. AstraZeneca Corporate Summary
Table 77. AstraZeneca Atypical Antipsychotic Drugs Product Offerings
Table 78. AstraZeneca Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Sumitomo Dainippon Pharma Corporate Summary
Table 80. Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Product Offerings
Table 81. Sumitomo Dainippon Pharma Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Qilu Pharmaceutical Corporate Summary
Table 83. Qilu Pharmaceutical Atypical Antipsychotic Drugs Product Offerings
Table 84. Qilu Pharmaceutical Atypical Antipsychotic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Atypical Antipsychotic Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Atypical Antipsychotic Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Atypical Antipsychotic Drugs Production by Region, 2017-2022 (K Units)
Table 88. Global Atypical Antipsychotic Drugs Production by Region, 2023-2028 (K Units)
Table 89. Atypical Antipsychotic Drugs Market Opportunities & Trends in Global Market
Table 90. Atypical Antipsychotic Drugs Market Drivers in Global Market
Table 91. Atypical Antipsychotic Drugs Market Restraints in Global Market
Table 92. Atypical Antipsychotic Drugs Raw Materials
Table 93. Atypical Antipsychotic Drugs Raw Materials Suppliers in Global Market
Table 94. Typical Atypical Antipsychotic Drugs Downstream
Table 95. Atypical Antipsychotic Drugs Downstream Clients in Global Market
Table 96. Atypical Antipsychotic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Atypical Antipsychotic Drugs Segment by Type
Figure 2. Atypical Antipsychotic Drugs Segment by Application
Figure 3. Global Atypical Antipsychotic Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Atypical Antipsychotic Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Atypical Antipsychotic Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Atypical Antipsychotic Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Atypical Antipsychotic Drugs Revenue in 2021
Figure 9. By Type - Global Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Atypical Antipsychotic Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Atypical Antipsychotic Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
Figure 19. US Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
Figure 24. Germany Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
Figure 33. China Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Atypical Antipsychotic Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Atypical Antipsychotic Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Atypical Antipsychotic Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Atypical Antipsychotic Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Atypical Antipsychotic Drugs by Region, 2021 VS 2028
Figure 50. Atypical Antipsychotic Drugs Industry Value Chain
Figure 51. Marketing Channels
